neoplas med
Neoplas Med is a privately held German medical technology company founded in 2009 and based in Greifswald that develops innovative products for medical applications, backed by strategic investors NGK Spark Plug Co and Pegasus Tech Ventures.
- Company typePrivate
- Founded2009
- HeadquartersGreifswald, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What neoplas med does
Neoplas Med is a Greifswald, Germany-based medical technology company founded in 2009 that develops innovative products for medical applications. Operating with a team of 11-50 employees, the company is positioned in the medical device sector, with the inputs placing it within the broader cold plasma medicine space — an industry valued at approximately $2.9B in 2024 with projected growth to over $11B by 2034 (per general cold plasma market sources). The company's specific product portfolio, technical specifications, and underlying device architecture are not disclosed in the available sources, though its geographic base in Greifswald — a recognized European hub for plasma research — and the domain neoplas-med.eu indicate a focus on plasma-based medical technology. Co-founder and partner Marko Häckel leads the founding team.
The business is currently privately held and pre-scale, with no disclosed revenue, pricing, customer base, or geographic footprint data. The company's go-to-market is not documented in the available sources; commercialization mechanics, distribution channels, and customer segmentation are all unstated. What is documented is the capital and partnership structure: Neoplas Med has attracted two rounds of investment — an initial 2023 round from NGK Spark Plug Co and Pegasus Tech Ventures, followed by a substantially larger $18,000,000 round in November 2024 led by NGK Spark Plug Co. This funding cadence, combined with the strategic corporate investor profile, suggests a company in a clinical or regulatory development phase preparing for commercial scale-up rather than one with mature revenue operations.
The key investment-relevant unknowns are significant: no certifications, patents, product names, regulatory milestones, or clinical trial data are disclosed in the inputs. The company's website (neoplas-med.eu) currently resolves only to a Cloudflare verification page, limiting first-party visibility. The dual investor base of a Japanese industrial components group (NGK Spark Plug) and a global technology venture firm (Pegasus Tech Ventures) implies strategic intent toward international expansion and channel access, particularly into Asian markets, but no concrete commercial milestones are available to validate execution progress.
neoplas med firmographics
Firmographics- Name
- neoplas med
- Website
- https://neoplas-med.eu
- Company type
- Private
- Founded year
- 2009
- Headcount range
- 11–50 employees
- Short description
- Neoplas Med is a privately held German medical technology company founded in 2009 and based in Greifswald that develops innovative products for medical applications, backed by strategic investors NGK Spark Plug Co and Pegasus Tech Ventures.
- Ownership category
- akta.pro rank
Where neoplas med is headquartered
LocationHeadquarters
- HQ city
- Greifswald
- HQ country
- Germany
- HQ region
- Europe
Markets served
neoplas med business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
neoplas med product offering
Product offeringCore offering
Neoplas Med develops innovative products for medical applications, operating within the cold plasma medical device segment. The company focuses on cold plasma-based therapeutic and medical solutions, positioned within a global cold plasma market valued at approximately $2.92 billion in 2024.
Differentiator
Problem solved
Functional benefit
Products and services
- Cold plasma medical products
Companies that use neoplas med
Customer profileIdeal customer profiles1 record
neoplas med technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
neoplas med partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights4 records
neoplas med competitors and assessment
Company assessmentEmerging players
- SteriBeam Systems: Developer of pulsed plasma / xenon-flash sterilization and decontamination systems for medical and life-science use. Comparable as an emerging player applying plasma technology to medical applications, though focused on sterilization rather than therapeutic indications.
Direct peers
- CINOGY Technologies: German specialist in cold plasma medical devices, with the PlasmaDerm product line for wound healing and dermatological indications. Directly competes with Neoplas Med in cold-plasma-based electrotherapy devices sold to clinicians.
- US Medical Innovations (USMI): US developer of cold atmospheric plasma technology aimed at oncology and wound care applications. Comparable to Neoplas Med in underlying plasma platform and clinical ambitions, though focused on a different geography.
- Adtec Healthcare: UK-based company that developed the Steriplas cold plasma device for chronic wound care and infectious skin conditions. Comparable as a cold-plasma medical-device competitor serving dermatology and wound-care markets.
- Coldplasmatech: Germany-based developer of cold atmospheric plasma medical devices, primarily for chronic wound care and dermatology. Closely comparable to Neoplas Med in technology (cold plasma), geography (Germany), and clinical focus.
Broad incumbents
- Apyx Medical: Public US medical device company selling plasma/RF-based surgical and aesthetic devices (Renuvion, J-Plasma). Comparable as a broader incumbent in plasma-based medical apparatus, with established commercial channels and regulatory infrastructure Neoplas Med lacks.
- Bovie Medical (now part of Apyx Medical): Established US manufacturer of electrosurgical and plasma-based devices. Comparable in underlying electrosurgical / plasma technology category, though substantially larger and more commercially mature.
- Erbe Elektromedizin: Large German family-owned manufacturer of electromedical and surgical devices, including electrosurgery and plasma-based instruments. Comparable as a broad incumbent in electromedical apparatus with global reach, but operating across a wider portfolio than Neoplas Med.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
neoplas med social profiles
Digital presenceneoplas med financial estimates
Financial estimateRevenue estimate
Valuation estimate
neoplas med leadership team
Management profileNumber of profiles
Profiles1 record
neoplas med funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
neoplas med M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about neoplas med
What does neoplas med do?
Neoplas Med develops innovative products for medical applications, operating within the cold plasma medical device segment. The company focuses on cold plasma-based therapeutic and medical solutions, positioned within a global cold plasma market valued at approximately $2.92 billion in 2024.
When was neoplas med founded?
neoplas med was founded in 2009. It employs 11 to 50 people.
Where is neoplas med based?
neoplas med is headquartered in Greifswald, Germany, in the Europe region.
Who are neoplas med's main competitors?
SteriBeam Systems is listed as an emerging player. Direct peers are CINOGY Technologies, US Medical Innovations (USMI), Adtec Healthcare and Coldplasmatech. Broad incumbents are Apyx Medical, Bovie Medical (now part of Apyx Medical) and Erbe Elektromedizin.
Does neoplas med have an API?
No public API is recorded for neoplas med.